Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

--- syzygium_cumini_l [2019/02/26 13:11] – andreas
+++ syzygium_cumini_l [2019/02/26 13:24] (aktuell) – andreas
@@ Zeile 15: / Zeile 15: @@
 [Effects of ethanolic extract of Syzygium cumini (Linn) seed powder on pancreatic islets of alloxan diabetic rats., Singh, N., Gupta, M., Indian journal of experimental biology, 45(10), 2007, 861] [[http://nopr.niscair.res.in/bitstream/123456789/5343/1/IJEB%2045%2810%29%20861-867.pdf]]
-"Overall, there isconvincing evidence that parts ofS. cuminihave antihy-perglycemic properties which has mainly been confirmedin a large amount of animal studies. Comparative studiesshow that in some models, drug preparations were equiva-lent to widely used oral antidiabetic agents. In contrast tothat, clinical studies done so far are insufficient to judgethe actual value ofS. cuminiin adjuvant diabetes therapy.Most clinical data seem not to be much more reliable thanpre-1900 case reports." \\
+"Overall, there is convincing evidence that parts of S. cumini have antihy-perglycemic properties which has mainly been confirmed in a large amount of animal studies. Comparative studies show that in some models, drug preparations were equivalent to widely used oral antidiabetic agents. In contrast to that, clinical studies done so far are insufficient to judge the actual value of S. cumini in adjuvant diabetes therapy. Most clinical data seem not to be much more reliable than pre-1900 case reports." \\
 [Kumar, A., et al. "Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats." Journal of Medicinal Plants Research 2.9 (2013): 246-249] [[http://www.academicjournals.org/journal/JMPR/article-full-text-pdf/A7B252015305]]